Pharmacogenetics of Tardive Dyskinesia: Combined Analysis of 780 Patients Supports Association with Dopamine D3 Receptor Gene Ser9Gly Polymorphism
β Scribed by Bernard Lerer; Ronnen H. Segman; Heiner Fangerau; Ann K. Daly; Vincenzo S. Basile; Roberto Cavallaro; Harald N. Aschauer; Robin G. McCreadie; Stephanie Ohlraun; Nicol Ferrier; Mario Masellis; Massimiliano Verga; Joachim Scharfetter; Marcella Rietschel; Roger Lovlie; Uriel Heresco Levy; Herbert Y. Meltzer; James L. Kennedy; Vidar M. Steen; Fabio Macciardi
- Book ID
- 114280995
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 179 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1470-634X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Dopamine D3 receptor (DRD3) was demonstrated to have important implications in schizophrenia, because it binds antipsychotic drugs and is abundant in the limbic system of the brain. Several groups attempted to find an association between a serine-to-glycine polymorphism at codon 9 of the DRD3 gene (